BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17305884)

  • 1. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).
    Rosenthal E; Pialoux G; Bernard N; Pradier C; Rey D; Bentata M; Michelet C; Pol S; Perronne C; Cacoub P;
    J Viral Hepat; 2007 Mar; 14(3):183-8. PubMed ID: 17305884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
    Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
    Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).
    Rosenthal E; Salmon-Céron D; Lewden C; Bouteloup V; Pialoux G; Bonnet F; Karmochkine M; May T; François M; Burty C; Jougla E; Costagliola D; Morlat P; Chêne G; Cacoub P;
    HIV Med; 2009 May; 10(5):282-9. PubMed ID: 19226410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).
    Rosenthal E; Poirée M; Pradier C; Perronne C; Salmon-Ceron D; Geffray L; Myers RP; Morlat P; Pialoux G; Pol S; Cacoub P;
    AIDS; 2003 Aug; 17(12):1803-9. PubMed ID: 12891066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.
    McMahon BJ; Bruden D; Bruce MG; Livingston S; Christensen C; Homan C; Hennessy TW; Williams J; Sullivan D; Rosen HR; Gretch D
    Gastroenterology; 2010 Mar; 138(3):922-31.e1. PubMed ID: 19909749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.
    Rosenthal E; Roussillon C; Salmon-Céron D; Georget A; Hénard S; Huleux T; Gueit I; Mortier E; Costagliola D; Morlat P; Chêne G; Cacoub P;
    HIV Med; 2015 Apr; 16(4):230-9. PubMed ID: 25522874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.
    Salmon-Ceron D; Rosenthal E; Lewden C; Bouteloup V; May T; Burty C; Bonnet F; Costagliola D; Jougla E; Semaille C; Morlat P; Cacoub P; Chêne G;
    J Hepatol; 2009 Apr; 50(4):736-45. PubMed ID: 19231018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
    Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
    J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
    Martín-Carbonero L; Sánchez-Somolinos M; García-Samaniego J; Núñez MJ; Valencia ME; González-Lahoz J; Soriano V
    J Viral Hepat; 2006 Dec; 13(12):851-7. PubMed ID: 17109686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of deaths related to Hepatitis C and AIDS in Scotland.
    Palmateer NE; Hutchinson SJ; McLeod A; Codere G; Goldberg DJ
    J Viral Hepat; 2007 Dec; 14(12):870-4. PubMed ID: 18070290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection.
    Vallet-Pichard A; Pol S
    J Hepatol; 2006; 44(1 Suppl):S28-34. PubMed ID: 16343684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.
    Jain MK; Skiest DJ; Cloud JW; Jain CL; Burns D; Berggren RE
    Clin Infect Dis; 2003 Apr; 36(8):1030-8. PubMed ID: 12684916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of liver disease in human immunodeficiency virus-infected patients.
    Puoti M; Moioli MC; Travi G; Rossotti R
    Semin Liver Dis; 2012 May; 32(2):103-13. PubMed ID: 22760649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients.
    Schreibman I; Gaynor JJ; Jayaweera D; Pyrsopoulos N; Weppler D; Tzakis A; Schiff ER; Regev A
    Transplantation; 2007 Sep; 84(6):697-705. PubMed ID: 17893602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.